Entry |
|
Name |
Neostigmine bromide;
Neo proserine
|
Formula |
C12H19N2O2. Br
|
Exact mass |
302.0630
|
Mol weight |
303.20
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07A PARASYMPATHOMIMETICS
N07AA Anticholinesterases
N07AA01 Neostigmine
D00995 Neostigmine bromide (JAN/USP/INN) <JP>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01EB Parasympathomimetics
S01EB06 Neostigmine
D00995 Neostigmine bromide (JAN/USP/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
12 Agents affecting peripheral nervous system
123 Autonomic nervous system agents
1233 Neostigmines
D00995 Neostigmine bromide (JAN/USP/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01595 Cholinesterase inhibitor
DG01593 Acetylcholinesterase inhibitor
DG00987 Neostigmine
D00995 Neostigmine bromide
DG01719 Parasympathomimetic agent
DG00987 Neostigmine
D00995 Neostigmine bromide
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Carboxylic-ester hydrolases
ACHE
D00995 Neostigmine bromide (JAN/USP/INN) <JP>
|
Other DBs |
|
KCF data |
ATOM 17
1 C8y C 23.6886 -16.9984
2 C8x C 24.9088 -16.2918
3 C8x C 23.6943 -18.4055
4 O7a O 22.4740 -16.2978
5 C8y C 26.1232 -16.9984
6 C8x C 24.9088 -19.1061
7 C7a C 21.2597 -17.0042
8 C8x C 26.1232 -18.3997
9 N1d N 27.3435 -16.2918 #+
10 N1c N 20.0394 -16.3035
11 O6a O 21.2597 -18.4114
12 C1a C 28.5228 -15.5096
13 C1a C 26.6779 -15.2294
14 C1a C 28.1667 -17.5004
15 C1a C 18.8308 -17.0101
16 C1a C 20.0394 -14.8965
17 X Br 31.2903 -17.3137 #-
BOND 16
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 4 7 1
7 5 8 2
8 5 9 1
9 7 10 1
10 7 11 2
11 9 12 1
12 9 13 1
13 9 14 1
14 10 15 1
15 10 16 1
16 6 8 1
|